Thomas Kustermann
Impact in
- Neurology top 5%
- Parkinson's Disease Mechanisms and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- Parkinson's Disease Mechanisms and Treatments 9
-
- Schizophrenia research and treatment 3
- Co-authors
- Tzvetan G. Popov (4 shared papers)Brigitte S. Rockstroh (4 shared papers)Gregory A. Miller (4 shared papers)Mauro Oddo (3 shared papers)Andrea O. Rossetti (3 shared papers)Matthias Hænggi (3 shared papers)Christian Pfeiffer (3 shared papers)Frédéric Zubler (3 shared papers)
- Journals
- Psychophysiology (2 papers)Movement Disorders (2 papers)Resuscitation (2 papers)The Lancet (1 paper)Nature Medicine (1 paper)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Thomas Kustermann
15 papers receiving 441 citations
Thomas Kustermann's Hit Papers
Peers
Comparison fields: 5 of 39
- Neurology 302
- Drug Discovery 1
- Neurology 23
- Emergency Medicine 23
- Cognitive Neuroscience 50
Countries citing papers authored by Thomas Kustermann
This map shows the geographic impact of Thomas Kustermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kustermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kustermann more than expected).
Fields of papers citing papers by Thomas Kustermann
This network shows the impact of papers produced by Thomas Kustermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kustermann. The network helps show where Thomas Kustermann may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Kustermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Trial of Prasinezumab in Early-Stage Parkinson’s Disease Hit paper breakdown → | 2022 | 291 |
| 2 | 2024 | 33 | |
| 3 | 2019 | 23 | |
| 4 | 2025 | 18 | |
| 5 | 2016 | 17 | |
| 6 | 2019 | 15 | |
| 7 | 2020 | 14 | |
| 8 | 2018 | 11 | |
| 9 | 2018 | 8 | |
| 10 | 2018 | 8 | |
| 11 | 2024 | 8 | |
| 12 | 2025 | 4 | |
| 13 | 2025 | 2 | |
| 14 | 2025 | 2 | |
| 15 | 2025 | 1 | |
| 16 | 2025 | 0 | |
| 17 | 2026 | 0 | |
| 18 | 2026 | 0 |
About Thomas Kustermann
Thomas Kustermann is a scholar working on Neurology, Psychiatry and Mental health, Cognitive Neuroscience, Emergency Medicine and Radiology, Nuclear Medicine and Imaging, having authored 18 papers that have together received 455 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (9 papers), Schizophrenia research and treatment (3 papers), Neural dynamics and brain function (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Cardiac Arrest and Resuscitation (2 papers), Traumatic Brain Injury Research (1 paper), Alzheimer's disease research and treatments (1 paper) and Functional Brain Connectivity Studies (1 paper). The work is most often cited by research in Neurology (302 citations), Drug Discovery (1 citation), Neurology (23 citations), Emergency Medicine (23 citations) and Cognitive Neuroscience (50 citations). Thomas Kustermann has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Tzvetan G. Popov, Brigitte S. Rockstroh, Gregory A. Miller, Mauro Oddo, Andrea O. Rossetti, Matthias Hænggi, Christian Pfeiffer, Frédéric Zubler, Marzia De Lucia E and Rebekka Kurmann. Their work appears in journals such as Psychophysiology, Movement Disorders, Resuscitation, The Lancet and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.